Recently, Li and co-workers (1) reported that lipomas occur more frequently in patients with hereditary retinoblastoma (RB) than in those with sporadic RB. They suggested that, in addition to a recognized susceptibility to second primary connective tissue cancers, patients with germline mutations of the retinoblastoma (RB1) gene may also be predisposed to lipomas. Here we present further cytogenetic and molecular genetic evidence for a link between germline RB1 gene mutations and lipoma through somatic loss of a RB1 allele in a patient with sporadic bilateral RB, a condition almost invariably caused by a germline RB1 mutation (2, 3) .
In 1961, binocular RB was diagnosed in a 1-year-old Caucasian male. Both of his eyes were enucleated after unsuccessful radiation therapy. Beginning at age 25, the patient has developed numerous large lipomas at the neck, shoulders, and other regions. He underwent surgery for these tumors in 1991, 1995, and 1996. He currently has developed a large lipoma in the neck and multiple smaller lipomas localized on both shoulders, the back, the chest, and the hip. This patient's family history revealed no relatives with RB, lipomas, or other tumors.
We performed cytogenetic studies as previously described (4,5) on one lipoma sample taken in 1995 from the posterior neck (lipoma 100/95) and on two samples taken in 1996-one from a tumor localized suprapubically (lipoma 314/96A) and one from a tumor of the shoulder (lipoma 314/96B). All three tumors were histologically ordinary lipomas. In two of the tumors, a deletion of a part of the long arm of a chromosome 13 was the sole karyotype abnormality (Table 1) . Lipoma 100/95 (Fig. 1, A) showed a large interstitial deletion encompassing chromosome segment 13q12-13q31, and lipoma 314/96B (Fig. 1, B) showed a small interstitial deletion, del(13) (q12-13q14). Lipoma 314/96A displayed a nearly triploid karyotype with 65-66 chromosomes and complex chromosome changes. Despite the nearly triploid chromosome set, a copy of chromosome 13 was missing in cells from tumor 314/96A. Fluorescence in situ hybridization (FISH) analyses of interphase nuclei using a 220-kilobase probe covering the entire RB1 gene (Vysis, Downers Grove, IL) confirmed the cytogenetic findings (6) . Both tumors 314/95 and 314/96B, which had interstitial deletions of 13q, exhibited one hybridization signal (in 68.3% and 92.2% of the nuclei from tumors 314/95 and 314/96B, respectively). Two spots were found in 78.1% of the nuclei of lipoma 314/96A, representing two copies of chromosome 13 carried by these cells.
For molecular genetic studies, genomic DNA was extracted from peripheral blood mononuclear cells, and tumor DNA was recovered from cultured lipoma cells (7) . To detect loss of heterozygosity (LOH), short tandem repeat polymorphisms (STRs) Rb1.20 and RBi2 of the RB1 gene were amplified by the polymerase chain reaction and analyzed with the use of an automated sequencer (ABI 373A; Applied Biosystems, Weiterstadt, Germany) (6, (8) (9) (10) . The patient exhibited germline heterozygosity for Rb1.20 (317 base pairs [bp] and 321 bp) and RBi2 (185 bp and 187 bp). In lipomas 100/95 and 314/ 96B, the 321-bp allele of Rb1.20 and the 187-bp allele of RBi2 were lost (Table 1) .
A deletion of the long arm of chromosome 13, with loss of chromosome band 13q14, is a chromosomal abnormality typical of sporadic, ordinary lipomas (5, (11) (12) (13) . However, to our knowledge, our case is the first to provide direct evidence by FISH and microsatellite studies of heterozygous loss of the RB1 gene in lipomas. In large lipomas, complete excision of the tumor may be hampered by widespread growth, allowing relapse due to residual lipoma tissue. However, because the deletion of 13q in lipoma 100/95 was greater than that in lipoma 314/96B, the two tumors were cytogenetically different although they were derived from neighboring regions. Thus, the 13q deletion most probably occurred independently in these two lipomas. Moreover, lipoma 314/96A showed unique cytogenetic abnormalities, as well as molecular genetic differences from the other lipomas. In con-trast, other researchers (12) have observed clonal chromosome abnormalities in only one of 58 lipomas in 18 patients with multiple lipomas.
The high incidence of clonal chromosome abnormalities in our patient represents a particular feature of his lipomas that may be related to a germline RB1 mutation.
It is generally accepted that all patients with sporadic bilateral RB are heterozygous for an oncogenic RB1 mutation (2, 3) . In our patient, chromosome analyses on peripheral blood lymphocytes as well on skin fibroblasts revealed a normal karyotype, and FISH investigations on nuclei of skin fibroblasts by use of the above-mentioned RB1 probe demonstrated a normal signal distribution (Table 1) .
Extensive screening for small mutations by use of heteroduplex analyses, single-strand conformation polymorphism analyses, and direct sequencing failed to disclose a RB1 mutation in peripheral blood mononuclear cell DNA. It is noteworthy that in a large study this screening procedure allowed for the detection of RB1 mutations in more than 80% of patients with hereditary RB (7, 10) . However, because of the complexity of the RB1 gene, mutations still may escape detection (6, 10, 14) . Moreover, somatic mosaicism of RB1 mutations has been reported in patients with sporadic bilateral RB (15) (16) (17) . On the other hand, recurrent loss of the same RB1 allele in two different lipomas of our patient further substantiates that a predisposing RB1 gene mutation, as was found in RBs and osteosarcomas from RB patients, may be involved in the development of this second primary neoplasm (18) (19) (20) (21) (22) (23) .
Ordinary lipomas almost never undergo malignant transformation (24) . Nevertheless, the presence of lipomas in RB patients may indicate an increased susceptibility to second cancers (1). So far, no association could be demonstrated between particular RB1 gene mutations and specific second primary tumors (10) . However, further studies aimed at the detection of an as yet un- discovered germline RB1 mutation in our patient, as well as combined cytogenetic and molecular genetic analyses of additional lipoma samples, may clarify the molecular basis for the increased incidence of lipomas in patients with hereditary RB.
